Caricamento...
The evidence for the use of recombinant factor VIIa in massive bleeding: revision of the transfusion policy framework
In 2006, the Canadian National Advisory Committee on Blood and Blood Products (NAC) developed a transfusion policy framework for the use of off-label recombinant factor VIIa (rFVIIa) in massive bleeding. Because the number of randomised controlled trials has doubled, the NAC undertook a review of th...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Blackwell Publishing Ltd
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3546370/ https://ncbi.nlm.nih.gov/pubmed/22630348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-3148.2012.01164.x |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|